Gastric cancer, Gastric adenoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients have been diagnosed with gastric adenoma or early gastric cancer (including suspected cases) in preoperative examinations and are scheduled to undergo ESD. 2 Preoperative endoscopic examination reveals that the tumor is 5cm or less in long diameter. 3 Patients are aged older than 18 years and younger than 90 years at the time of enrollment. 4 Patients have been fully informed about participating in the study and have given their consent.
Exclusion criteria
Exclusion criteria: 1 Cases in which multiple lesions are scheduled to be treated on the same day 2 Cases in which the tumor length exceeds 5 cm 3 Cases in the postoperative stomach 4 Cases in which 14-day follow-up after ESD is not possible 5 Cases that the investigator deems inappropriate 6 Cases in which it is difficult to suspend antithrombotic drugs according to the guidelines 7 Cases in which patients undergoing hemodialysis 8 Cases in which patients with reduced renal function (Cre>2.0mg/mL) or reduced platelet count (PLT<5.0*10^7/mL) in preoperative blood sampling
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of delayed bleeding within 14 days after ESD | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory findings in blood tests (WBC, CRP) the day after ESD Rate of occurrence of symptoms (fever and abdominal pain) related to post-electrocoagulation syndrome Time required for preventive treatment for bleeding Cost required for preventive treatment for bleeding Rate of occurrence of other adverse events including delayed perforation within 14 days after ESD Total length of hospital stay | — |
Countries
Japan
Contacts
Kyoto Prefectural University of Medicine Molecular Gastroenterology and Hepatology, Graduate School of Medical Science